WLF
  • Who We Are
    • Legal Policy Advisory BoardA select group of legal professionals that provides informal guidance on a volunteer basis.
    • Annual ReportOur yearly look back at litigation and legal studies activities undertaken in the public interest.
    • WLF Senior StaffDescriptions of WLF’s senior leadership.
    • Featured
      In Op-Ed, WLF Advisory Board Member Questions FDA “Crackdown” on Pharma Ads

      In a December 9, 2025 Washington Examiner op-ed, WLF Legal Policy Advisory Board member and former Food & Drug Administration (FDA) Chief Counsel, Dan Troy, criticized federal regulators’ approach to direct-to-consumer (DTC) advertising of prescription drugs.

      Read More
  • What We Do
    • Litigation
      Litigation is the backbone of WLF’s public-interest efforts. WLF litigates before state and federal courts and agencies nationwide.
      • Cases
      • Regulatory Matters
      • Month in Review
    • Legal Studies
      Successfully advocating for a legal and regulatory environment that fosters free enterprise requires the timely dissemination and steady reinforcement of compelling arguments and ideas to those lawyers and jurists who shape the law.
      • Publications
      • WLF Legal Pulse blog
      • Programming
    • Our Issues
      WLF’s vital work to uphold the legal principles that support our free enterprise system are categorized into:
      • Government Regulation
      • Combating Litigation Abuse
      • Economic & Individual Liberties
  • News
    • Press ReleasesAnnouncements of litigation filings and other WLF developments.
    • Media MentionsSee where our work has been mentioned in the media.
    • Featured Case
      National Retail Federation v. James

      On January 13, 2026, WLF urged the Second Circuit to reverse a district court decision upholding a New York law imposing a large and ominous disclaimer on targeted ads promoting...

      Read More
  • Get Involved
    • Pro BonoLearn how you can volunteer to advance our mission.
    • DonateWLF relies upon tax-deductible contributions as a 501(c)(3) charity.
    • Contact Us
    • Featured
      A Threat to M&A Market Vitality: “Break-Up Fee” Taxation in the Pending Appeal of AbbVie v. Comm. of Internal Revenue

      A U.S. Tax Court ruling properly invalidated an IRS policy change that threatened to diminish mergers & acquisitions, the appeal of which the agency should strongly consider dropping.

      Read More
Donate
Search
Donate

Search WLF

49 years of Keeping Free Enterprise Free. Search all current and past litigation and legal studies.

Search
WLF
  • Privacy Policy
  • Subscribe
2009 Massachusetts Ave., NW Washington, D.C. 20036
© 2026 WLF. All rights reserved.

This site uses cookies for performance, site traffic analysis, and social media purposes. Find out more about our cookie policy here. You can adjust your preferences in cookie settings.